Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference
October 10 2017 - 6:15PM
PR Newswire (US)
WASHINGTON, Oct. 10, 2017 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it
will host investor meetings at the Oppenheimer Specialty Pharma
Summit Conference in New York City
on Wednesday, October 11, 2017.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-oppenheimer-specialty-pharma-summit-conference-300534383.html
SOURCE Vanda Pharmaceuticals Inc.
Copyright 2017 PR Newswire
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Sep 2023 to Sep 2024